(Hypertension. 2002;39:363.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Correspondence to Takao Saruta, MD, Professor of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan, E-mail saruta{at}sc.itc.keio.ac.jp
| Abstract |
|---|
|
|
|---|
Key Words: renin-angiotensin system phospholipase
| Introduction |
|---|
|
|
|---|
Phospholipase C (PLC) and phospholipase D (PLD) are involved in the second messenger pathways in cellular responses to angiotensin II (Ang II)2,3 and mechanical stimulation,47 and activation of these enzymes leads to the generation of inositol 1,4,5-trisphosphate (IP3), which promotes calcium release from intracellular calcium stores.8 Recent studies have demonstrated that PLC contributes to increases in inositol phosphates evoked by mechanical distension in renin-expressing As4.1 cells9 and pressure-mediated vasoconstriction in afferent arterioles,10 which are metaplastically transformed to JG cells.11,12 However, there is no experimental evidence indicating that PLC and PLD play roles in modulating pressure control of renin synthesis and secretion in JG cells.
The purpose of this study was to test the hypothesis that transmural pressure controls renin synthesis and secretion through activation of PLC and PLD in JG cells. In the presence and absence of enzyme inhibitors selective for PLC or PLD, JG cells were subjected to a transmural pressure-loading apparatus devised in our laboratory.1
| Methods |
|---|
|
|
|---|
Pressure-Loading JG Cells
Pressure was loaded on JG cells with a minimal contribution from shear stress or stretch, as reported previously.1 The 8-well chamber slides were placed in a sanitary pressure vessel (model DV-5-ST; Advantec Toyo) prewarmed to 37°C. The pressure vessel was then sealed tightly and connected to tubing attached to a 3-way rotary valve, a sphygmomanometer, and a pressure valve. Compressed helium was pumped in to raise the internal pressure. The sanitary pressure vessel was then placed in the incubator, and the internal temperature was kept constant at 37°C. During the experiments, the loaded pressure level was monitored with a sphygmomanometer. The partial pressure of oxygen and the pH of the medium averaged 155±4 mm Hg and 7.4±0.1, respectively, and were kept constant throughout the experiments. In addition to atmospheric pressure, JG cells were subjected to transmural pressures of 0 and 40 mm Hg in the present study.
Measurement of Renin Secretion Rate, Active Renin Content, and Total Renin Content in JG Cells
The renin secretion rate (RSR), active renin content (ARC), and total (active + inactive) renin content (TRC) were measured in JG cells as described previously.1 In brief, after the culture medium had been removed, the cells were washed twice with prewarmed phosphate-buffered saline (PBS). Each well was filled with 1 mL of Ca2+-containing PBS and placed in the pressure-loading apparatus. Immediately before (0 hours) and 12 hours after the pressure loading, the cell-conditioned buffer was removed and centrifuged. The supernatants were stored at -20°C until renin activity was assayed for determination of RSR. After rinsing with PBS, the cells were frozen in liquid nitrogen and stored at -80°C. For assay of ARC and TRC, frozen cells were homogenized in 1 mL of buffer (pH 6.0) containing (in mmol/L) 2.6 ethylenediaminetetraacetate, 1.6 dimercaprol, 3.4 8-hydroxyquinoline sulfate, 0.2 phenylmethylsulfonyl fluoride, and 5 ammonium acetate. The homogenates were centrifuged at 12 000g for 30 minutes, and the supernatant was removed. To measure TRC in JG cells, the samples (900 µL) were incubated at 0°C for 60 minutes with 100 µL of 4 mg/mL trypsin (Sigma Chemical Co., St. Louis, MO) in 500 mmol/L Tris buffer (pH 7.5) containing 5 mmol/L CaCl2, 0.1% NaCl azide, and 1% bovine serum albumin, as described previously.15 Soybean trypsin inhibitor (8 mg/mL final concentration; Sigma Chemical Co.) was added to stop the reaction. Thus, inactive renin in the samples was converted to active renin, and renin activity was then determined.
Renin activity was determined as previously described.14 Samples were incubated for 1 hour at 37°C with plasma from bilaterally nephrectomized male Sprague-Dawley rats as the renin substrate, and renin activity was determined by the generation of Ang I from a plasma angiotensinogen substrate. Ang I levels were measured using a radioimmunoassay coated-bead kit from Dinabott Radioisotope Institute (Tokyo, Japan). RSR (%) was calculated as the fractional release of overall active renin (ie, [buffer renin activity at 12 hours - buffer renin activity at 0 hours]/[ARC in JG cells at 12 hours + buffer renin activity at 12 hours - buffer renin activity at 0 hours]). JG cell ARC and TRC were expressed as the renin activity of the sample obtained per million cells.
Experimental Protocols
Primary JG cell cultures were divided into 2 groups, atmospheric pressure and atmospheric pressure+40 mm Hgloaded wells for 12 hours. Each group included at least 2 wells, and mean values per primary culture were determined in each group. In the first series of experiments, we assessed the contribution of PLC-dependent pathways to transmural pressure control of renin synthesis and secretion. The cells were conditioned in control buffer or buffer containing the PLC inhibitor 2-nitro-4-carboxyphenyl-N,N-diphenyl-carbamate (NCDC, 200 µmol/L; Sigma Chemical Co) during the pressure load. In the second series of experiments, which also examined the involvement of PLC in transmural pressure control of renin regulation, the cells were conditioned in buffer containing another PLC inhibitor, U73122 (10 µmol/L; Sigma Chemical Co), or its inactive analog, U73343 (10 µmol/L; Sigma Chemical Co), during the pressure load. NCDC (200 µmol/L) and U73122 (10 µmol/L) concentrations were chosen on the basis of previous studies demonstrating that 200 µmol/L NCDC and 5 µmol/L U73122 significantly inhibit afferent arteriolar constriction caused by Ang II and pressure, respectively.10,16 The contribution of PLD to transmural control of renin regulation was examined in the third series of experiments. The cells were conditioned in control buffer or buffer including the PLD inhibitor 4-(2-aminoethyl)-benzensulfonyl fluoride (AEBSF, 100 µmol/L; Sigma Chemical Co) during the pressure load. A previous study demonstrated that AEBSF inhibits basal- and agonist-stimulated PLD activity (IC50=75 µmol/L) but does not influence the activities of either PLC or phospholipase A2.17
Statistical Analysis
Data were analyzed by paired t test. Differences between treatments were assessed by 2-way analysis of variance followed by multiple comparisons using Scheffes F test for repeated measures. A value of P<0.05 was considered significant. Data are presented as mean±SEM.
| Results |
|---|
|
|
|---|
|
Treatment with NCDC did not influence ARC under atmospheric pressure or the transmural pressureinduced decrease in ARC. Addition of 40-mm Hg transmural pressure significantly decreased ARC in untreated cells (42.8±3.3 and 26.0±3.9 ng of Ang I · h-1 · million cells-1 for atmospheric pressure and atmospheric pressure+40 mm Hg, respectively) and cells treated with NCDC (50.8±9.5 and 28.0±5.0 ng of Ang I · h-1 · million cells-1 for atmospheric pressure and atmospheric pressure+40 mm Hg, respectively). The ARC decreases were similar in untreated cells and those treated with NCDC.
Neither the addition of transmural pressure nor treatment with NCDC changed TRC in JG cells. In untreated cells, TRC averaged 99.5±6.7 ng of Ang I · h-1 · million cells-1 and was not altered by addition of 40-mm Hg transmural pressure (89.2±4.6 ng of Ang I · h-1 · million cells-1). In the cells treated with NCDC, TRC averaged 107.8±8.9 ng of Ang I · h-1 · million cells-1 and was similar to TRC in untreated cells. Addition of 40-mm Hg transmural pressure did not change TRC (93.5±5.9 ng of Ang I · h-1 · million cells-1). In cells treated with 200 µmol/L NCDC, trypan blue exclusion staining showed cell viabilities of 94.8±1.8 and 95.4±1.6% after 12-hour loads of atmospheric pressure and atmospheric pressure+40 mm Hg, respectively.
Effects of U73122 and U73343 on Transmural Pressure Controls of Renin
Figure 2 demonstrates the effects of 12 hours of exposure to transmural pressure on RSR, ARC, and TRC in JG cells treated with U73122 or its inactive analog U73343 at 10 µmol/L (n=5 primary cultures). In the cells treated with U73343, addition of 40-mm Hg transmural pressure significantly decreased RSR from 70.8±3.2 to 46.5±4.6%. In the cells treated with U73122, however, addition of 40-mm Hg transmural pressure did not alter RSR (73.9±3.9 and 72.4±3.5% for atmospheric pressure and atmospheric pressure+40 mm Hg, respectively). RSR of the U73122-treated cells was similar to that of the U73343-treated cells in the group of cells conditioned with atmospheric pressure and significantly greater than that of the U73343-treated cells in the group of cells conditioned with atmospheric pressure+40 mm Hg. Thus, treatment with U73122 prevented the pressure-induced decrease in RSR.
|
In the cells treated with U73343, addition of 40-mm Hg transmural pressure significantly decreased ARC from 55.4±4.4 to 31.9±4.3 ng of Ang I · h-1 · million cells-1. In the cells treated with U73122, addition of 40-mm Hg transmural pressure also decreased ARC from 55.5±1.9 to 35.6±2.0 ng of Ang I · h-1 · million cells-1. The pressure-induced decrease in ARC was similar in the cells treated with U73343 and U73122.
TRC in the cells treated with U73343 and U73122 averaged 106.1±6.6 and 107.0±11.1 ng of Ang I · h-1 · million cells-1, respectively. Addition of 40-mm Hg transmural pressure did not influence TRC in either cells treated with U73343 (104.8±6.4 ng of Ang I · h-1 · million cells-1) or those treated with U73122 (109.4±17.1 ng of Ang I · h-1 · million cells-1). Trypan blue exclusion staining indicated respective cell viabilities of 97.8±0.6 and 97.2±0.4% in the atmospheric pressureloaded cells treated with U73343 and U73122 and respective cell viabilities of 97.1±0.6 and 96.8±0.4% in the atmospheric pressure+40 mm Hgloaded cells treated with U73343 and U73122.
Effects of AEBSF on Transmural Pressure Control of Renin
Figure 3 illustrates the effects of 12 hours of exposure to transmural pressure on RSR, ARC, and TRC in untreated JG cells and cells treated with 100 µmol/L AEBSF (n=5 primary cultures). In untreated control cells, addition of 40-mm Hg transmural pressure significantly reduced RSR from 73.0±1.9 to 48.6±2.0%. In the cells treated with AEBSF, RSR under atmospheric pressure averaged 68.8±3.4% and was similar to the RSR of untreated cells. Addition of 40-mm Hg transmural pressure also significantly decreased RSR to 43.9±3.5%. The decreases in RSR were similar in untreated cells and cells treated with AEBSF.
|
ARC in untreated control cells averaged 69.6±9.0 and 38.8±2.4 ng of Ang I · h-1 · million cells-1 for atmospheric pressure and atmospheric pressure+40 mm Hg, respectively, such that transmural pressure significantly decreased ARC. Treatment with AEBSF did not influence ARC of the atmospheric pressureloaded cells (66.4±13.2 ng of Ang I · h-1 · million cells-1) but did prevent the pressure-induced decrease in ARC. In cells treated with AEBSF, ARC of the atmospheric pressure+40 mm Hgloaded cells averaged 59.4±14.4 ng of Ang I · h-1 · million cells-1 and was similar to that obtained under atmospheric pressure. In the group of cells conditioned with atmospheric pressure+40 mm Hg, ARC of the AEBSF-treated cells was significantly greater than that of the control buffertreated cells.
Neither addition of transmural pressure nor treatment with AEBSF changed TRC in JG cells. In untreated cells, TRC averaged 127.4±17.9 ng of Ang I · h-1 · million cells-1 and was not altered by addition of 40-mm Hg transmural pressure (120.2±19.0 ng of Ang I · h-1 · million cells-1). In cells treated with AEBSF, TRC averaged 115.2±8.4 ng of Ang I · h-1 · million cells-1 and was similar to TRC in untreated cells. Addition of 40-mm Hg transmural pressure did not change TRC (105.6±5.1 ng of Ang I · h-1 · million cells-1). In the AEBSF-treated cells, trypan blue exclusion staining indicated cell viabilities of 95.2±1.4 and 95.6±1.3% after 12-hour loads of atmospheric pressure and atmospheric pressure+40 mm Hg, respectively.
| Discussion |
|---|
|
|
|---|
Chronic cyclic stretch significantly decreased renin secretion in both JG cells and renin-expressing CaLu-6 cells.18 Although acute mechanical stretch caused Ca2+ influx in renin-expressing As4.1 cells, chronic mechanical stretch not only causes Ca2+ influx but also activates PLC and inositol phosphates and subsequently mobilizes intracellular Ca2+ stores.9 These results suggest that PLC-dependent pathways play an important role in maintenance of the Ca2+ response during chronic mechanical stimulation leading to suppression of renin secretion. In addition, our previous study demonstrated that inhibition of renin release by chronic transmural pressure loading is suppressed by removal of Ca2+ from extracellular fluids and by an L-type Ca2+ channel blocker.1 These results suggest that chronic transmural pressure loading may initiate a decrease in renin secretion via Ca2+ influx and then continue inhibiting renin secretion from JG cells by stimulating PLC activity.
Our previous study demonstrated prorenin processing inhibition by chronic transmural pressure loading to be dependent on intracellular Ca2+ stores.1 PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate to generate IP3 and 1,2-diacylglycerol, which promote release of Ca2+ from intracellular stores and activation of protein kinase C, respectively.7 PLD hydrolyzes phosphatidylcholine to choline and phosphatidic acid.19 Phosphatidic acid is known to stimulate IP3 generation and the subsequent mobilization of intracellular Ca2+.20 Because activation of either PLC or PLD causes IP3-dependent Ca2+ release from intracellular stores, we hypothesized that chronic transmural pressure loading may modulate renin synthesis and secretion in JG cells through activation of PLC and PLD. However, in the present study, the PLD inhibitor AEBSF inhibited pressure control of prorenin processing, whereas PLC inhibitors did not. A recent study demonstrated that Ang IIinduced protein synthesis and cell growth, occurring within minutes or hours, depend on PLD activity in vascular smooth muscle cells.3 However, Ang II also induces activation of PLC, which occurs within seconds, resulting in rapid vascular contraction. These observations suggest that PLD is also involved in intracellular signaling pathways distinct from PLC-dependent pathways. Therefore, transmural pressure may inhibit prorenin processing in JG cells through PLD-dependent pathways distinct from PLC-dependent mobilization of intracellular Ca2+.
Cyclic nucleotides play an important role in renin synthesis and secretion in JG cells.21 However, transmural pressure control of renin does not involve cAMP-dependent pathways, because the adenylate cyclase activator forskolin does not influence transmural pressure control of renin synthesis or secretion.1 Studies demonstrated that PLD-dependent signaling pathways are involved in NADPH oxidase-dependent superoxide formation3,22 and that superoxide has an inhibitory effect on cyclic guanosine monophosphate (GMP) formation in vascular smooth muscle cells.23 In JG cells, therefore, PLD-dependent pathways may influence active renin synthesis through the modulation of intracellular cyclic GMP levels as a result of superoxide production.
PLD and its lipid product, phosphatidic acid, are required for vesicle transport from the endoplasmic reticulum to the Golgi complex,24 in which prorenin is processed to active renin.25 Although the reason that PLD is required for vesicle transportation is unknown, altered transport of prorenin vesicle may account for the PLD-dependent suppression of prorenin processing by transmural pressure. The other possible mechanisms by which PLD inhibits conversion of inactive to active renin may be due to the regulation of DNA synthesis by phosphatidic acid.26,27 Because a chronic transmural pressure load has no effect on renin mRNA levels,1 phosphatidic acid may modulate expression of gene related with processing enzyme activities. Additional studies are needed to elucidate the PLC-independent, PLD-dependent signaling pathways that are responsible for transmural pressure control of prorenin processing in JG cells.
Because afferent arteriolar smooth muscle cells transform metaplastically into JG cells,11,12 the nature of the pressure-induced intracellular signal transduction may be maintained in JG cells. In afferent arterioles of isolated perfused hydronephrotic rat kidneys, increasing pressure gates mechanosensitive cation channels and causes membrane depolarization and activation of voltage-dependent Ca2+ channels.28 In afferent arterioles of the blood-perfused juxtamedullary nephron, U73122 significantly attenuated vasoconstrictor responses to increasing pressure, suggesting that PLC is involved in the afferent arteriolar constriction in response to increasing pressure.10 In addition, P2 purinoceptors have been demonstrated to be involved in pressure-mediated afferent arteriolar constriction,29 leading to ATP mobilizing Ca2+ from intracellular stores in preglomerular vascular smooth muscle cells, including afferent arteriolar smooth muscle cells.30 Furthermore, activation of PLC has been implicated in the ATP-mediated mobilization of Ca2+ from intracellular stores.31 These studies suggest that both Ca2+ influx and PLC-dependent intracellular Ca2+ mobilization play important roles in the regulation of afferent arteriolar diameters in response to pressure loading. Likewise, when combined with our previous study,1 the present results show that Ca2+ influx, intracellular Ca2+ mobilization, PLC, and PLD contribute to the regulation of renin secretion and synthesis in JG cells via pressure loading.
In conclusion, at the JG cell level, a 12-hour transmural pressure load decreases RSR and ARC without influencing TRC, suggesting that transmural pressure loading inhibits renin secretion and prorenin processing to active renin in JG cells. Decreases in RSR and ARC with the pressure loading were inhibited by the PLC inhibitors NCDC and U73122 and the PLD inhibitor AEBSF, respectively. Thus, PLC and PLD play important roles in the inhibition of renin secretion and prorenin processing in response to a chronic transmural pressure load.
| Acknowledgments |
|---|
Received September 23, 2001; first decision October 25, 2001; accepted November 6, 2001.
| References |
|---|
|
|
|---|
2. Freeman EJ. The Ang II-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism. Arch Biochem Biophys. 2000; 374: 363370.[CrossRef][Medline] [Order article via Infotrieve]
3. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension. 1999; 34: 976982.
4. Osol G, Laher I, Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol. 1993; 265: H415H420.[Medline] [Order article via Infotrieve]
5. DAngelo G, Meininger GA. Transduction mechanisms involved in the regulation of myogenic activity. Hypertension. 1994; 23(6 pt 2): 10961105.
6. Matsumoto H, Baron CB, Coburn RF. Smooth muscle stretch-activated phospholipase C activity. Am J Physiol. 1995; 268: C458C465.[Medline] [Order article via Infotrieve]
7. Narayanan J, Imig M, Roman RJ, Harder DR. Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol. 1994; 266: H1840H1845.[Medline] [Order article via Infotrieve]
8. Griendling KK, Tsuda T, Berk BC, Alexander RW. Angiotensin II stimulation of vascular smooth muscle. J Cardiovasc Pharmacol. 1989; 14 (suppl 6): S27S33.
9. Ryan MJ, Gross KW, Hajduczok G. Calcium-dependent activation of phospholipase C by mechanical distension in renin-expressing As4.1 cells. Am J Physiol. 2000; 279: E823E829.
10. Inscho EW, Cook AK, Mui V, Imig JD. Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction. Hypertension. 1998; 31: 421428.
11. Barajas L. Anatomy of the juxtaglomerular apparatus. Am J Physiol. 1979; 237: F333F343.[Medline] [Order article via Infotrieve]
12. Taugner R, Bührle CP, Hackenthal E, Mannek E, Nobiling R. Morphology of the juxtaglomerular apparatus and secretory mechanisms. Contrib Nephrol. 1984; 43: 76101.[Medline] [Order article via Infotrieve]
13. Ichihara A, Suzuki H, Murakami M, Naitoh M, Matsumoto A, Saruta T. Interactions between angiotensin II and norepinephrine on renin release by juxtaglomerular cells. Eur J Endocrinol. 1995; 133: 569577.
14. Ichihara A, Kobori H, Miyashita Y, Hayashi M, Saruta T. Differential effects of thyroid hormone on renin secretion, content, and mRNA in juxtaglomerular cells. Am J Physiol. 1998; 274: E224E237.[Medline] [Order article via Infotrieve]
15. Campbell WG Jr, Gahnem F, Catanzaro DF, James GD, Camargo MJF, Laragh JH, Sealey JE. Plasma and renal prorenin/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension. 1996; 27: 11211133.
16. Takenaka T, Suzuki H, Fujiwara K, Kanno Y, Ohno Y, Hayashi K, Nagahama T, Saruta T. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest. 1997; 100: 21072114.[Medline] [Order article via Infotrieve]
17. Andrews B, Bond K, Lehman JA, Horn JM, Dugan A, Gomez-Cambronero J. Direct inhibition of in vitro PLD activity by 4-(2-aminoethyl)-benzenesulfonyl fluoride. Biochem Biophys Res Commun. 2000; 273: 302311.[CrossRef][Medline] [Order article via Infotrieve]
18. Carey RM, McGrath HE, Pentz ES, Gomez RA, Barrett PQ. Biomechanical coupling in renin-releasing cells. J Clin Invest. 1997; 100: 15661574.[Medline] [Order article via Infotrieve]
19. Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem. 1996; 273: 1658616590.
20. Kurz T, Wolf RA, Corr PB. Phosphatidic acid stimulates inositol 1,4,5-trisphosphate production in adult cardiac myocytes. Circ Res. 1993; 72: 701706.
21. Bader M, Ganten D. Regulation of renin: new evidence from cultured cells and genetically modified mice. J Mol Med. 2000; 78: 130139.[CrossRef][Medline] [Order article via Infotrieve]
22. Bellavite P, Corso F, Dusi S, Grzeskowiak M, Della-Bianca V, Rossi F. Activation of NADPH-dependent superoxide production in plasma membrane extracts of pig neutrophils by phosphatidic acid. J Biol Chem. 1988; 263: 82108214.
23. Wu L, de Champlain J. Effects of superoxide on signaling pathways in smooth muscle cells from rats. Hypertension. 1999; 34: 12471253.
24. Bi K, Roth MG, Ktistakis NT. Phosphatidic acid formation by phospholipase D is required for transport from the endoplasmic reticulum to the Golgi complex. Curr Biol. 1997; 7: 301307.[CrossRef][Medline] [Order article via Infotrieve]
25. King JA, Lush DJ, Fray JCS. Regulation of renin processing and secretion: chemiosmotic control and novel secretory pathway. Am J Physiol. 1993; 265: C305C320.[Medline] [Order article via Infotrieve]
26. Moolenaar WH, Kruijer W, Tilly BC, Verlaan I, Bierman AJ, deLaat SW. Growth factor-like action of phosphatidic acid. Nature. 1986; 323: 171173.[CrossRef][Medline] [Order article via Infotrieve]
27. Knauss TC, Jaffer FE, Abboud HE. Phosphatidic acid modulates DNA synthesis, phospholipase C, and platelet-derived growth factor mRNAs in cultured mesangial cells. J Biol Chem. 1990; 265: 1445714463.
28. Takenaka T, Suzuki H, Okada H, Hayashi K, Kanno Y, Saruta T. Mechanosensitive cation channel mediate afferent arteriolar myogenic constriction in the isolated rat kidney. J Physiol. 1998; 1998: 245253.
29. Inscho EW, Cook AK, Navar LG. Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am J Physiol. 1996; 271: F1077F1085.[Medline] [Order article via Infotrieve]
30. Inscho EW, Belott TP, Mason MJ, Smith JB, Navar LG. Extracellular ATP increases cytosolic calcium in cultured rat renal arterial smooth muscle cells. Clin Exp Pharmacol Physiol. 1996; 23: 503507.[Medline] [Order article via Infotrieve]
31. Dubyak GR, El-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol. 1993; 265: C577C606.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
N. Lehman, M. Di Fulvio, N. McCray, I. Campos, F. Tabatabaian, and J. Gomez-Cambronero Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2 Blood, November 15, 2006; 108(10): 3564 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ichihara, Y. Kaneshiro, T. Takemitsu, M. Sakoda, T. Nakagawa, A. Nishiyama, H. Kawachi, F. Shimizu, and T. Inagami Contribution of Nonproteolytically Activated Prorenin in Glomeruli to Hypertensive Renal Damage J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2495 - 2503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ichihara, F. Suzuki, T. Nakagawa, Y. Kaneshiro, T. Takemitsu, M. Sakoda, A.H.M. N. Nabi, A. Nishiyama, T. Sugaya, M. Hayashi, et al. Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor-Deficient Mice J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1950 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ichihara, Y. Kaneshiro, T. Takemitsu, M. Sakoda, F. Suzuki, T. Nakagawa, A. Nishiyama, T. Inagami, and M. Hayashi Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic Hypertension Hypertension, May 1, 2006; 47(5): 894 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, L. C. Carey, J. Liu, N. K. Valego, S. B. Tatter, and J. C. Rose The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1279 - R1287. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |